Patterns of concurrent chemotherapy selection in US patients undergoing trimodality therapy for muscle-invasive bladder cancer

被引：0
|
作者：
Callihan, Eryn [1 ]
Kuna, Elizabeth Molina [2 ]
Robin, Tyler P. [3 ]
Eule, Corbin J. [4 ]
Kim, Simon P. [5 ]
Flaig, Thomas W. [1 ]
机构：
[1] Univ Colorado, Canc Ctr, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Populat Hlth Shared Resource, Canc Ctr, Aurora, CO USA
[3] Univ Colorado Anschutz Med Campus, Aurora, CO USA
[4] Univ Colorado, Div Med Oncol, Canc Ctr, Aurora, CO USA
[5] Univ Colorado Denver, Dept Urol Oncol, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-148; 261-566-148-11342; 261-566-3248-2667; 283-183-138-226-11080; 6; 5; 3; 2; 176; 300; 62; 3590;
D O I：
10.1200/JCO.2024.42.4_suppl.554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：554 / 554
页数：1
相关论文
共 50 条
  • [1] Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough
    Winquist, Eric
    Booth, Christopher M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (24) : 2709 - +
  • [2] Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Royce, Trevor J.
    Liu, Yuan
    Milowsky, Matthew, I
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 362 - 368
  • [3] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Johnson, Skyler B.
    Yu, James B.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [4] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Chen, Ronald C.
    Shipley, William U.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
  • [5] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Skyler B. Johnson
    James B. Yu
    Current Oncology Reports, 2018, 20
  • [6] Patterns of Failure After Definitive Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Kotha, Nikhil, V
    Kumar, Abhishek
    Riviere, Paul
    Nelson, Tyler J.
    Qiao, Edmund M.
    Salmasi, Amirali
    Mckay, Rana R.
    Efstathiou, Jason A.
    Rose, Brent S.
    Stewart, Tyler F.
    CLINICAL GENITOURINARY CANCER, 2025, 23 (01)
  • [7] Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival
    Tang, Yaxiong
    Lin, Lede
    Xiao, Yunfei
    Meng, Linghao
    Yang, Yujia
    Li, Xiang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (02): : 446 - 455
  • [8] Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival
    Yaxiong Tang
    Lede Lin
    Yunfei Xiao
    Linghao Meng
    Yujia Yang
    Xiang Li
    Clinical and Translational Oncology, 2024, 26 : 446 - 455
  • [9] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [10] Genomic Determinants of Response to Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Kamran, S. C.
    Zhou, Y.
    Otani, K.
    Drumm, M. R.
    Otani, Y.
    Wu, S.
    Wu, C. L.
    Borger, D.
    Lennerz, J. K.
    Van Allen, E. M.
    Willers, H.
    Hong, T. S.
    Liu, Y.
    Davicioni, E.
    Gibb, E.
    Shipley, W. U.
    Mouw, K. W.
    Efstathiou, J. A.
    Miyamoto, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S24 - S24
12345